Physical activity is associated with lower arterial stiffness in older adults: results of the SAPALDIA 3 Cohort Study by Endes, Simon et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2016
Physical activity is associated with lower arterial stiffness in older adults:
results of the SAPALDIA 3 Cohort Study
Endes, Simon; Schaffner, Emmanuel; Caviezel, Seraina; Dratva, Julia; Autenrieth, Christine Sonja;
Wanner, Miriam; Martin, Brian; Stolz, Daiana; Pons, Marco; Turk, Alexander; Bettschart, Robert;
Schindler, Christian; Künzli, Nino; Probst-Hensch, Nicole; Schmidt-Trucksäss, Arno
Abstract: Associations of physical activity (PA) intensity with arterial stiffness in older adults at the
population level are insufficiently studied. We examined cross-sectional associations of self-reported PA
intensities with arterial stiffness in elderly Caucasians of the Swiss Cohort Study on Air Pollution and
Lung and Heart Diseases in Adults. Mixed central and peripheral arterial stiffness was measured oscillo-
metrically by the cardio-ankle vascular index (CAVI) and brachial-ankle pulse wave velocity (baPWV).
The self-reported International Physical Activity Questionnaire long version was administered to clas-
sify each subject’s PA level. We used univariable and multivariable mixed linear and logistic regression
models for analyses in 1908 persons aged 50 years and older. After adjustment for several confounders
moderate, vigorous and total PA were inversely associated with CAVI (p = 0.02-0.03). BaPWV showed
negative and marginally significant associations with vigorous and moderate PA (each p = 0.06), but
not with total PA (p = 0.28). Increased arterial stiffness (CAVI ￿ 9, upper tertile) was inversely and
significantly associated with vigorous PA [odds ratio (OR) 0.65, 95 % confidence interval (CI) 0.48-0.88],
and marginally significantly with total PA (OR 0.76, 95 % CI 0.57-1.02) and moderate PA (OR 0.75, 95
% CI 0.56-1.01). The odds ratio for baPWV ￿ 14.4 was 0.67 (95 % CI 0.48-0.93) across the vigorous PA
levels, and was non-significant across the total (OR 0.91, 95 % CI 0.66-1.23) and moderate PA levels (OR
0.94, 95 % CI 0.69-1.28). In this general Caucasian population of older adults higher levels especially of
vigorous PA were associated with lower arterial stiffness. These data support the importance of PA for
improving cardiovascular health in elderly people.
DOI: 10.1007/s10654-015-0076-8
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-117035
Accepted Version
Originally published at:
Endes, Simon; Schaffner, Emmanuel; Caviezel, Seraina; Dratva, Julia; Autenrieth, Christine Sonja; Wan-
ner, Miriam; Martin, Brian; Stolz, Daiana; Pons, Marco; Turk, Alexander; Bettschart, Robert; Schindler,
Christian; Künzli, Nino; Probst-Hensch, Nicole; Schmidt-Trucksäss, Arno (2016). Physical activity is as-
sociated with lower arterial stiffness in older adults: results of the SAPALDIA 3 Cohort Study. European
Journal of Epidemiology, 31(3):275-285. DOI: 10.1007/s10654-015-0076-8
Title: Physical Activity is Associated With Lower Arterial Stiffness in Older Adults: 1 
Results of the SAPALDIA 3 Cohort Study 2 
Short title: Physical activity and arterial stiffness 3 
Running head: Physical activity and arterial stiffness 4 
Simon Endes1, Emmanuel Schaffner2,3, Seraina Caviezel2,3, Julia Dratva2,3, Christine S. 5 
Autenrieth2,3, Miriam Wanner4, Brian Martin4, Daiana Stolz5, Marco Pons6, Alexander Turk7, 6 
Robert Bettschart8, Christian Schindler2,3, Nino Künzli2,3, Nicole Probst-Hensch2,3 and Arno 7 
Schmidt-Trucksäss1 8 
1Department of Sport, Exercise and Health, Div. Sports and Exercise Medicine, University of 9 
Basel, Switzerland 10 
2Swiss Tropical and Public Health Institute, Basel, Switzerland 11 
3University of Basel, Basel, Switzerland 12 
4Physical Activity and Health Working Unit, Institute of Social and Preventive Medicine, 13 
University of Zurich, Switzerland. 14 
5Clinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, 15 
Switzerland 16 
6Division of Pulmonary Medicine, Regional Hospital Lugano, Lugano Switzerland 17 
7Zürcher Höhenklinik, Wald-Faltigberg, Faltigberg-Wald, Switzerland 18 
8Lungenpraxis Hirslanden Klinik Aarau, Aarau, Switzerland 19 
Correspondence: Simon Endes, Department of Sport, Exercise and Health, Div. Sports and 20 
Exercise Medicine, University of Basel, Birsstrasse 320B, 4052 Basel, CH. Tel: +41 61 377 21 
87 44; fax: +41 61 377 87 42; e-mail: simon.endes@unibas.ch 22 
23 
2 
 
Abstract 24 
Associations of physical activity (PA) intensity with arterial stiffness in older adults at the 25 
population level are insufficiently studied. We examined cross-sectional associations of self-26 
reported PA intensities with arterial stiffness in elderly Caucasians of the Swiss Cohort Study 27 
on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA). Mixed central and 28 
peripheral arterial stiffness was measured oscillometrically by the cardio-ankle vascular index 29 
(CAVI) and brachial-ankle pulse wave velocity (baPWV). The self-reported International 30 
Physical Activity Questionnaire (IPAQ) long version was administered to classify each 31 
subject’s PA level. We used univariable and multivariable mixed linear and logistic 32 
regression models for analyses in 1908 persons aged 50 years and older. After adjustment for 33 
several confounders moderate, vigorous and total PA were inversely associated with CAVI (p 34 
= 0.02-0.03). BaPWV showed negative and marginally significant associations with vigorous 35 
and moderate PA (each p = 0.06), but not with total PA (p = 0.28). Increased arterial stiffness 36 
(CAVI ≥ 9, upper tertile) was inversely and significantly associated with vigorous PA (Odds 37 
Ratio (OR) = 0.65, 95% Confidence Interval (CI): 0.48-0.88), and marginally significantly 38 
with total PA (OR = 0.76, 95% CI: 0.57-1.02) and moderate PA (OR = 0.75, 95% CI: 0.56-39 
1.01). The odds ratio for baPWV ≥ 14.4 was 0.67 (95% CI: 0.48-0.93) across the vigorous PA 40 
levels, and was non-significant across the total (OR = 0.91, 95% CI: 0.66-1.23) and moderate 41 
PA levels (OR = 0.94, 95% CI: 0.69-1.28). In this general Caucasian population of older 42 
adults higher levels especially of vigorous PA were associated with lower arterial stiffness. 43 
These data support the importance of PA for improving cardiovascular health in elderly 44 
people. 45 
Keywords: arterial stiffness, cardiovascular disease prevention, epidemiology, physical 46 
exercise, prevention  47 
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Background 48 
Physical inactivity is regarded as one of the main risk factors for both non-communicable 49 
diseases in general and cardiovascular diseases in particular [1]. 6% of the burden of disease 50 
from coronary heart disease and 9% of premature deaths worldwide in 2008 are attributable to 51 
physical inactivity [2]. Adherence to physical activity (PA) guidelines is suggested to reduce 52 
the mortality rate by 25% [3] and an increase of PA by 10% or 25% could prevent more than 53 
533’000 or 1.3 million deaths, respectively, per year worldwide [2]. A physically active 54 
lifestyle is linked with decreased risk of cardiovascular diseases and events at all ages through 55 
improvements in arterial stiffness reflecting arterial remodeling [4–6]. Arterial stiffness is a 56 
reversible, non-invasive structural biomarker of potentially grave cardiovascular 57 
modifications and is independently associated with cardiovascular disease and events [7,8]. 58 
Stiffening of the arteries is closely linked with ageing related elastin degeneration and 59 
collagen proliferation reflecting vascular ageing [9].  60 
The current European Guidelines on cardiovascular disease prevention in clinical practice of 61 
the European Society of Cardiology [10] and physical activity guidelines [11] recommend a 62 
minimum of 150 minutes per week of at least moderate intensity for adults to beneficially 63 
impact on the population health and cardiovascular mortality. However, in larger samples 64 
associations between PA intensities and arterial stiffness have so far mainly been analyzed 65 
regarding central arterial stiffness in adolescents and middle-aged persons [12–15]. In two 66 
population based studies of older adults walking speed was inversely associated with central 67 
arterial stiffness [16,17]. Besides, there are only two medium sized cross-sectional studies 68 
showing that PAs of different intensities are associated with lower central arterial stiffness in 69 
older adults [18,19].  70 
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The cardio-ankle vascular index (CAVI) and brachial-ankle pulse wave velocity (baPWV) are 71 
mixed measures of central and peripheral arterial stiffness that have mainly been studied in 72 
Asian populations so far [20,21]. There are no data on the population level in older adults of 73 
the association between different intensities of PA and arterial stiffness measured by CAVI 74 
and baPWV. Therefore, we examined associations of self-reported PA intensities with these 75 
arterial stiffness indices in the Swiss Cohort Study on Air Pollution and Lung and Heart 76 
Diseases in Adults (SAPALDIA). 77 
Methods 78 
Study design and participants 79 
SAPALDIA 3 is the second follow-up assessment of an ongoing multi-center cohort study 80 
including eight distinct rural and urban areas which represent the environmental and 81 
demographic diversity of Switzerland (Aarau, Basel, Davos, Geneva, Lugano, Montana, 82 
Payerne, Wald) [22,23]. SAPALDIA was initiated in 1991 to investigate the association of air 83 
pollution and lung diseases among randomly selected adults (18 to 60 years, N = 9651). 84 
SAPALDIA 3 additionally focused on cardiovascular health assessment and arterial stiffness 85 
was measured in 3068 subjects of the cohort aged at least 50 years. The respective Swiss 86 
cantonal ethical committees have granted ethical approval and participants gave written 87 
informed consent. 88 
Arterial stiffness measurement 89 
Mixed central and peripheral arterial stiffness was measured oscillometrically and 90 
simultaneously by CAVI and baPWV using a non-invasive VaSera VS-1500N vascular 91 
screening system (Fukuda Denshi, Tokyo, Japan). All measurements were taken in supine 92 
position after ten minutes of rest in a quiet room with constant temperature. Blood cuffs were 93 
placed at each upper arm and above each ankle. ECG electrodes at each wrist and a 94 
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phonocardiogram on the sternal border in the second intercostal space were applied to detect 95 
the initial notch of the pulse waves at the heart and the ankle on average over six heart cycles. 96 
The time delay of the pulse wave from the heart to the ankle was determined by a foot-to-97 
foot-method. Vascular length between the heart valve and the ankle artery was estimated by 98 
the VSS-10 software (Fukuda Denshi) using a height based formula [24]. The PWV is 99 
calculated by dividing the arterial length by the time delay of the pulse wave. CAVI is then 100 
automatically derived from Bramwell-Hill´s equation and the stiffness parameter ß with an 101 
inclusion of the PWV [25]. Therefore, CAVI is less dependent on blood pressure at the time 102 
of measurement than aortic PWV[26] and baPWV [27]. The average of two consecutive 103 
measurements at 3-5 minute intervals and of both body sides was taken for analyses. The 104 
CAVI and baPWV reproducibility was previously shown to be high in this Caucasian cohort 105 
[28]. CAVI reflects arterial stiffness of the aorta and the iliac, femoral and tibial arteries [25] 106 
and baPWV between the brachial and tibial arteries [29]. Since both of these indices cover 107 
different segments of the arterial tree, they reflect a combination of central and peripheral 108 
arterial stiffness [20,21].  109 
Physical activity assessment 110 
The self-reported International Physical Activity Questionnaire (IPAQ) long version was 111 
administered to classify the PA level in 3072 individuals [30]. The IPAQ long form asks for 112 
the frequency and duration of moderate and vigorous PA in different domains performed 113 
during the last seven days (leisure time PA, domestic and gardening (yard) activities, work-114 
related PA, transport-related PA) [31]. Moderate and vigorous intensities were associated 115 
with harder and much harder breathing, respectively. Minutes per week of moderate PA 116 
(including walking), vigorous PA and total PA as a sum of minutes per week of moderate and 117 
vigorous PA were calculated following the IPAQ guidelines [31]. They were weighted by 118 
their energy cost as metabolic equivalents (MET) with one MET equating to around one 119 
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kcal/kg/hour, which approximately corresponds to sitting quietly. This leads to a MET-120 
minutes per week score reflecting total energy expenditure [32]. Total PA is therefore a 121 
combined measure of amount and intensity of PA in terms of MET-minutes per week of 122 
moderate and vigorous PA. We calculated levels (“low”, “medium” and “high”) of each 123 
category of PA (moderate, vigorous and total PA). Levels of moderate and total PA were 124 
calculated by tertile classes. Vigorous PA was not categorized in tertiles due to the clustering 125 
of answers (56.8% of subjects reported no vigorous PA and 6.2% reported 960 MET-126 
min/week of vigorous PA). All subjects without vigorous PA were assigned to the lowest 127 
level of vigorous PA (N=1084). Since 118 subjects reported on exactly 960 MET-min/week 128 
of vigorous PA corresponding to the threshold between the medium and high level of 129 
vigorous PA, these subjects were all assigned to the medium level to achieve the best possible 130 
balance of group sizes. Thus, the chosen categorization of vigorous PA is the best 131 
approximation to a categorization by tertiles as for moderate and total PA. 132 
Statistical analyses 133 
If not stated otherwise, data are expressed as median (25th and 75th percentile). Comparisons 134 
of the variables of interest by PA levels were performed by using t test, nonparametric median 135 
test (Kruskal Wallis test) or χ2 test, as appropriate and age associations by linear regression. 136 
CAVI and baPWV were analyzed as continuous outcomes and when stated in dichotomized 137 
form, with a threshold for increased arterial stiffness of 9 for CAVI (comparing the highest to 138 
the lower two tertiles) and of 14.4 m/s for baPWV (comparing the highest to the lower two 139 
tertiles), respectively. We used univariable (Model 1) and multivariable mixed linear and 140 
logistic regression models for analyses including a random area effect to account for the 141 
multi-center study setting. In Model 2, the association of arterial stiffness with PA was 142 
adjusted for age and sex and in Model 3 additionally for body mass index, smoking status 143 
defined as packyears up to SAPALDIA 3, educational status, mean arterial pressure, heart 144 
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rate, and medication. Medication intake was categorized in two classes: 0, no cardiovascular 145 
or metabolic disease related medication; 1, medication for kidney disease, diabetes, 146 
hyperlipidemia, hypertension, stroke, myocardial infarction, heart failure, angina and 147 
arrhythmia. We a priori defined and investigated several potentially important interactions 148 
and included the interaction terms age-sex and sex-mean arterial pressure in the final Model 4 149 
based on the inclusion criteria p = 0.1. We used backward selection of variables using the 150 
Akaike Information Criterion (AIC) and tested non-linear terms using residual-versus-151 
predicted-plots to derive the best fitting model. All statistical analyses were performed using 152 
the statistical software STATA (StataCorp LP, Release 12, Texas, USA) with p = 0.05 as 153 
significance level.  154 
Results 155 
Subject Characteristics 156 
In 1908 out of 3068 individuals data of both arterial stiffness and IPAQ were available. The 157 
analytic sample was on average significantly older (63.3 vs 58 years, p < 0.001) and had 158 
significantly lower baPWV (13.8 vs 14.1 m/s, p < 0.001), body mass index (26.1 vs 26.5 159 
kg/m2, p < 0.05), total PA (5279 vs 5810 MET-min/week, p < 0.05), vigorous PA (1023 vs 160 
1454 MET-min/week, p < 0.001), mean arterial pressure (99.3 vs 100.3 mmHg, p < 0.05) and 161 
heart rate (61.9 vs 63.1 bpm, p < 0.05) compared to the whole arterial stiffness and IPAQ 162 
sample of SAPALDIA 3. CAVI, moderate PA and the number of smoking packyears were not 163 
significantly different. The main characteristics by vigorous PA levels are listed in Table 1. 164 
Associations of Age and Sex With Physical Activity and Arterial Stiffness 165 
A significant sex difference with respect to PA was present only in vigorous PA with higher 166 
values in males (p < 0.001) (Supplemental Table S1). There was a significant age associated 167 
decline in total PA for females (p < 0.01 oldest to youngest age category), but not for males (p 168 
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= 0.71) (Supplemental Table S2). Vigorous PA decreased significantly in both sexes with 169 
increasing age category (p < 0.001 oldest to youngest age category). Moderate PA increased 170 
in both sexes from the age of 50-59 years to 60-69 years, significantly only in males (p < 171 
0.01; females p = 0.09), and decreased in older participants with higher amounts of moderate 172 
PA compared to age 50-59 years significant only in males (p = 0.03), but not in females (p = 173 
0.53). CAVI and baPWV increased significantly with age in both sexes (every p < 0.001); 174 
CAVI on average by 0.9 per decade and baPWV by 1.8 m/s, respectively (Supplemental Fig. 175 
S1). Statistically significant gender differences were observed for CAVI in the age groups 60-176 
69 (p < 0.001) and 70-81 (p < 0.01) and for baPWV in the age groups 50-59 (p = 0.01) and 177 
60-69 (p < 0.01) , with lower values among women (Supplemental Fig. S1). 178 
Association of Physical Activity With Arterial Stiffness 179 
In the univariable analyses the means of CAVI and baPWV both decreased across levels of 180 
moderate, vigorous and total PA, however significantly only for vigorous PA (every p < 181 
0.001), where more than a third of the participants did not report on any vigorous PA Table 3 182 
and 4 show the regression results for CAVI and baPWV as a function of PA for each of the 183 
four models. In the multivariable analyses of CAVI there was a significant inverse association 184 
of CAVI with PA after adjustment in Model 2 for total and vigorous PA comparing the high 185 
with the low PA level (each p = 0.04) and for moderate PA comparing the medium with the 186 
low PA level (p = 0.03), but not between high and low PA (p = 0.09).This inverse association 187 
was strengthened upon further adjustment in Model 3 with significant associations between 188 
the high and low PA level for total (p = 0.03) and vigorous PA (p = 0.02) and marginally 189 
significant for moderate PA comparing medium and low PA (p = 0.05), but not high and low 190 
PA (p = 0.10). Inclusion of the interaction terms age-sex and sex-mean arterial pressure in 191 
Model 4 further strengthened the associations of CAVI with the respective PA levels (p = 192 
0.02-0.03). BaPWV showed negative and marginally significant associations with vigorous 193 
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PA comparing the high with the low level and with moderate PA comparing the medium with 194 
the low level (each p = 0.06), but not significantly with total PA after adjustment in Model 3 195 
and 4.  196 
There was a significant positive age-sex (each p = 0.03) and marginally significant positive 197 
sex-mean arterial pressure interaction (each p = 0.05) in the models estimating the association 198 
between CAVI and PA. With increasing mean arterial pressure, the sex difference in CAVI 199 
increased, with higher values in males for moderate, vigorous and total PA (exemplarily for 200 
total PA in Supplemental Fig. S2). The interaction terms were not statistically significant in 201 
the baPWV models. 202 
The fully adjusted (Model 4) CAVI means decreased significantly from 8.67 to 8.56 from the 203 
high to the low total PA level, similarly from 8.64 to 8.53 for vigorous PA and from 8.67 for 204 
the low moderate PA level to 8.57 for the medium moderate PA level (Fig 1). The fully 205 
adjusted baPWV means decreased non-significantly from 13.78 to 13.65 m/s across total PA 206 
levels (from low to medium), from 13.77 to 13.60 m/s for vigorous PA (from low to high) and 207 
from 13.80 to 13.63 m/s for moderate PA (from low to medium).  208 
Odds Ratios 209 
The marginal probability of CAVI ≥ 9 decreased from 0.37 to 0.31 (p < 0.01) significantly 210 
across vigorous PA levels with an odds ratio (OR) of 0.65 (95% Confidence Interval (CI): 211 
0.48-0.88) for the highest level compared to the lowest, and marginally significant from 0.37 212 
to 0.33 across total PA levels (p = 0.07, OR 0.76, 95% CI: 0.57-1.02), and from 0.38 to 0.34 213 
across moderate PA levels (p = 0.06, OR 0.75, 95% CI: 0.56-1.01). These results are derived 214 
from mixed logistic regression analyses with the same adjustment as in Model 4 (Table 2 and 215 
Supplemental Fig S3). Similarly, the marginal probability of baPWV ≥ 14.4 decreased 216 
significantly from 0.33 to 0.28 for vigorous PA levels (p = 0.02, OR 0.67, 95% CI: 0.48-217 
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0.93), but non-significantly across the total (from 0.33 to 0.32, p = 0.53, OR 0.91, 95% CI: 218 
0.66-1.23) and moderate PA levels (from 0.33 to 0.32, p = 0.69, OR 0.94, 95% CI: 0.69-1.28). 219 
Discussion 220 
The results of this cross-sectional study in a very well characterized cohort of elderly 221 
Caucasian subjects from the general population suggest that higher levels of self-reported PA 222 
are associated with lower arterial stiffness, even after adjustment for several potential 223 
confounders. Especially vigorous PA was linked with lower arterial stiffness in this ageing 224 
population. These data support the importance of PA for improving cardiovascular health in 225 
elderly people and suggest that vigorous PA promotion in this age group may prevent against 226 
increased arterial stiffness resulting from atherosclerotic processes.  227 
Our results are in agreement with previous cross-sectional studies which suggest that higher 228 
levels of PA may have a protective effect on the vascular system [16,17]. Thereby, it has to be 229 
kept in mind, that the effect of PA on arterial stiffness varies across the arterial tree [15,33]. In 230 
a comparable cohort of older adults of the Whitehall II study higher arterial stiffness 231 
measured as carotid-femoral PWV was strongly associated with reduced walking speed and 232 
self-reported physical functioning [16]. Similarly, lower walking speed was linked with 233 
increased carotid-femoral PWV in a general population aged 70-79 years of the Health ABC 234 
Study, however, this association was dependent on the presence of hypertension and other 235 
vascular risk factors [17]. Aoyagi et al. examined the association of habitual PA (>3 236 
metabolic equivalents) measured by step counts and arterial stiffness in 198 Japanese people 237 
aged 65-84 years [33]. They reported on a beneficial effect of PA on the stiffening of central 238 
arteries, but not on the peripheral vasculature. Controversial results can be found regarding 239 
the intensity-dependence of this PA effect. In a medium sized longitudinal study particularly 240 
PA at higher intensity was favorable regarding central and peripheral arterial stiffness in 241 
11 
 
younger persons [14,15]. In the only study analyzing baPWV and PA intensities an increase 242 
in moderate-to-vigorous PA, but not light intensity PA, was linked with a decrease of baPWV 243 
in 274 overweight and obese young adults longitudinally within one year [20]. In 103 244 
postmenopausal women moderate and vigorous PA was inversely associated with central 245 
arterial stiffness [19]. Yet, also long-term maintenance of low intensity PA was associated 246 
with lower central arterial stiffness in older adults [18].  247 
Intervention studies with rather small sample sizes have demonstrated that arterial stiffness 248 
may be modifiable by exercise training in older adults [34–36]. A one year vigorous 249 
endurance exercise program improved arterial stiffness indices in twelve persons aged on 250 
average 70.3 years, who were sedentary before [34]. However, a short-term twelve week 251 
moderate intensity PA program did not change arterial stiffness in 113 persons aged 50-80 252 
[37]. Five recent systematic reviews of intervention studies show conflicting results 253 
concerning the effects of exercise interventions on arterial stiffness. Two of them found a 254 
significant positive effect of aerobic exercise on arterial stiffness especially at higher intensity 255 
[35,36], however neither in pre- and hypertensive [38] nor in middle-aged and older obese 256 
persons [39]. The results regarding resistance training are controversial ranging from negative 257 
effects [40] to beneficial effects depending on the intensity, muscle groups involved and the 258 
movement execution [35,36]. The discrepancies in these results may be due to whether or not 259 
non-randomized controlled trials have been included in the reviews, small sample sizes for 260 
subgroup analyses, different arterial stiffness measures, and varying statistical analyses. Thus, 261 
intervention study results show that there are beneficial effects of exercise training on arterial 262 
stiffness depending on the intensity and modality [34–37]. Our results show an association in 263 
line with these intervention study effects in terms of a beneficial relationship between higher 264 
amounts of regularly performed PA, especially at higher intensity, on arterial stiffness in older 265 
adults at the population level. 266 
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CAVI and baPWV are valid vascular biomarkers for non-invasive arterial stiffness 267 
assessment and are associated with cardiovascular disease risk and outcomes [41–44]. Both 268 
CAVI and baPWV have shown good correlations with central arterial stiffness [29,45]. In a 269 
systematic review of clinical studies, a 1 m/s reduction in baPWV was associated with an 270 
increase in total cardiovascular events, cardiovascular mortality, and all-cause mortality by 271 
12%, 13%, and 6%, respectively [43].CAVI is methodologically based on the baPWV 272 
measurement with improvements regarding the correlation with blood pressure [25]. Since 273 
CAVI is mathematically derived from the stiffness parameter β and a modified Bramwell-Hill 274 
equation, CAVI could be shown to be less dependent on the blood pressure at the time of 275 
measurement compared to baPWV [27]. CAVI includes stiffness of the aorta, femoral artery 276 
and tibial artery [25], whereas baPWV reflects the PWV to the upper arm and foot ignoring 277 
the influence of PWV to the arm as a possible modifier of the overall stiffness without precise 278 
definition of the distance from the heart to the upper arm [46]. These differences between 279 
CAVI and baPWV might explain that both indices do not show exactly the same results 280 
concerning their association with PA. However, they point to consistent conclusions towards 281 
lower arterial stiffness with higher PA. 282 
CAVI and baPWV were on average 0.10 and 0.16 m/s, respectively, lower in persons of the 283 
high PA level compared to the low PA level across moderate, vigorous and total PA in the 284 
fully adjusted Model 4. Thereby, it has to be kept in mind that moderate and total PA levels 285 
have been generated according to tertiles of MET-min/week, while this was not possible for 286 
vigorous PA where more than a third of subjects (N=1084) did not report on any vigorous. In 287 
this general population aged 50 to 81 years, CAVI increased significantly on average by 0.87 288 
per decade and baPWV by 1.84 m/s (see Supplemental Fig. S3). Therefore, higher levels of 289 
PA were associated with a favorable decrease of CAVI corresponding to around 1.1 years and 290 
for baPWV to 0.9 years of age related decrease in arterial stiffness independent of the main 291 
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confounding factors. This strengthens the evidence that PA can be implemented in 292 
cardiovascular health guidelines to counteract the vascular aging process and prevent early 293 
vascular aging as suggested by Nilsson et al. [9].Nevertheless, due to the cross-sectional 294 
design of this study causality and reverse causality concerning PA and arterial stiffness cannot 295 
be answered. Up-to-date there are no studies on sedentary behavior and systemic arterial 296 
stiffness, however sitting time has been shown to be related to higher wave reflections [47], 297 
augmentation index [48] and carotid arterial stiffness [49].  298 
Presently, there are no comparable IPAQ data for a Swiss population based cohort. According 299 
to the Eurobarometer 64.3 our study sample of the Swiss general population of older adults 300 
would rank as one of the most active European nations (median total PA 3971 MET-301 
minutes/week) [50]. This is in line with reports that 73% of Swiss adults meet the current PA 302 
guidelines according to the recent Swiss health survey [51] and is consistent with the 2014 303 
Swiss report on sports activity, in which Switzerland ranks 2nd behind Sweden in a European 304 
comparison [52,53]. However, only 43% of our ageing population reported on vigorous PA. 305 
This part of the population showed a beneficial inverse association of vigorous PA with 306 
arterial stiffness compared to subjects without vigorous PA. This result indicates that 307 
population based PA interventions and guidelines for older adults should incorporate and 308 
promote vigorous PA to improve cardiovascular health. 309 
Self-reported medication is commonly used for assessing disease in epidemiological studies 310 
and is related to diagnosed disease as shown for diabetes [54]. Assessment of disease by self-311 
report of medication may be prone to information bias due to non-reporting leading to 312 
misclassification. However, it can be assumed that this would be nondifferential 313 
misclassification without affecting the estimates in this cohort study. Besides, medical 314 
treatment is commonly based on clear disease indications and it has been shown, that self-315 
reported medical history is accurately related to cardiovascular and metabolic disease [56,57]. 316 
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Furthermore, patients’ self-reported cardiovascular and diabetic medication use has been 317 
found to be reliable [58]. 318 
Study Limitations 319 
This is a cross-sectional study, which does not enable inferring a causal association between 320 
PA and arterial stiffness in these adults aged at least 50 years. Reporting bias might have 321 
affected the self-reported PA assessment. However, the IPAQ has been developed and 322 
validated by Craig et al. as a cross-national monitoring tool of PA and physical inactivity for 323 
adults aged 15-69 years and represents a feasible, reliable and valid measurement instrument 324 
of PA [30]. While the IPAQ is prone to over-estimating PA especially in adults aged ≥65 325 
years [59], this is less the case for vigorous PAs such as structured sports or exercise activities 326 
[60], which showed the strongest association with arterial stiffness in our study. Due to 327 
logistic and financial reasons, objective PA measurements could not be implemented in the 328 
current study.  329 
Conclusions 330 
In summary, PA of higher intensity was independently associated with lower mixed central 331 
and peripheral arterial stiffness in this cross-sectional analysis of a cohort of older adults. The 332 
probability of having increased arterial stiffness was lower in more physically active persons. 333 
Regular vigorous PA may counteract vascular aging and, thus, reduce the population risk of 334 
cardiovascular disease and events. It is highly recommended to further strengthen the 335 
significance of vigorous PA in cardiovascular health guidelines in these age groups. 336 
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Figure legends 514 
Fig. 1 Fully adjusted (Model 4) means of cardio-ankle-vascular-index (CAVI) and brachial-515 
ankle pulse wave velocity (baPWV) across total, vigorous and moderate physical activity 516 
(PA) levels. * p < 0.05 compared to low PA level. 517 
 518 
Supplemental figure legends 519 
Fig. S1 Box plots of cardio-ankle-vascular-index (CAVI) and brachial-ankle pulse wave 520 
velocity (baPWV) by sex and age. Box represents 25th percentile (lower edge), median 521 
(middle bar) and 75th percentile (upper edge). Whiskers show the extent of the rest of the 522 
data; points indicate outliers. 523 
Fig. S2 Fully adjusted (Model 4) means of cardio-ankle-vascular-index (CAVI) over mean 524 
arterial pressure by sex and total physical activity (PA) levels (low, medium, high). 525 
Fig. S3 Marginal probability of cardio-ankle vascular index (CAVI) >=9 and brachial-ankle 526 
pulse wave velocity (baPWV) >=14.4 m/s across total, vigorous and moderate physical 527 
activity (PA) levels. * p < 0.05 compared to low PA level. 528 
Figure 1
Click here to download Figure: Fig1_fully adjusted margins_revised.tiff 
Table 1. Study population main characteristics across vigorous physical activity (PA) levels (N=1898). 
  Vigorous PA level  
 Units Low (N=1084) Medium (N=326) High (N=488) P-value 
Age years 65.0 (59.0; 70.9) 61.7 (55.8; 66.4) 60.9 (54.7; 66.3) <0.001 
baPWV m/s 13.07 (12.27; 15.42) 13.00 (11.48; 14.60) 13.00 (11.48; 14.60) <0.001 
CAVI no unit 8.72 (7.93; 9;47) 8.34 (7.64; 9.20) 8.40 (7.69; 9.05) <0.001 
Mean arterial pressure  mmHg 99 (92; 107) 98 (90; 105) 99 (92; 107) 0.37 
Heart rate  bpm 62 (56; 69) 59 (54; 64) 60 (54; 65) <0.001 
Body mass index kg/m2 26.0 (23.3; 29.1) 25.3 (22.6; 27.5) 25.4 (23.0; 28.3) 0.01 
Smoking packyears 0.4 (0; 20.0) 0 (0; 14.5) 2.0 (0; 20.0) 0.02 
Moderate PA MET-min/week 2832 (1356; 5292) 2753 (1449; 5202) 4821 (2588; 8148) <0.001 
Vigorous PA MET-min/week 0 (0; 0) 680 (480; 960) 2880 (1860; 4580) <0.001 
Total PA  MET-min/week 2832 (1356; 5292) 3455 (2130; 6036) 8236 (5384; 11909) <0.001 
Medication 
0 
1 
 
N (%) 
647 (34.1) 
437 (23.0) 
N (%) 
230 (12.1) 
96 (5.1) 
N (%) 
337 (17.8) 
151 (8.1) 
<0.001 
Medication for  N (%) N (%) N (%)  
Kidney disease  3 (0.2) 3 (0.2) 0 (0)  
Diabetes  2 (0.1) 6 (0.3) 14 (0.7)  
Hyperlipidemia  190 (10.0) 42 (2.2) 62 (3.3)  
Hypertension  308 (16.2) 70 (3.7) 103 (5.4)  
Stroke  17 (0.9) 4 (0.2) 5 (0.3)  
Myocardial infarction  20 (1.1) 6 (0.3) 8 (0.4)  
Heart failure  8 (0.4) 2 (0.1) 4 (0.2)  
Angina pectoris  15 (0.8) 1 (0.1) 9 (0.5)  
Arrhythmia  40 (2.1) 8 (0.4) 10 (0.5)  
Education 
Low 
Middle 
High 
 
N (%) 
64 (3.4) 
700 (36.9) 
320 (16.9) 
N (%) 
10 (0.5) 
213 (11.2) 
103 (5.4) 
N (%) 
18 (0.9) 
328 (17.3) 
142 (7.5) 
0.15 
tables 1-4
Click here to download table: Tables 1-4_2_sc_SE.docx 
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BaPWV, brachial-ankle pulse wave velocity; CAVI, cardio-ankle vascular index; Education low, primary school; middle, 
secondary school, middle school or apprenticeship; high, Technical College or University; Medication 0, no cardiovascular or 
metabolic disease related medication; 1, medication for kidney disease, diabetes, hyperlipidemia, hypertension, stroke, myocardial 
infarction, heart failure, angina and arrhythmia; MET, metabolic equivalent; PA, physical activity. Values are median and 25th, 
75th percentile or N (%). Percentages and p-values for comparisons across vigorous PA levels. Percentages may not add up to 
100% due to rounding. 
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Table 2. Odds ratios (OR) of cardio-ankle vascular index (CAVI) ≥ 9 and brachial-ankle pulse wave velocity (baPWV) ≥ 14.4 m/s 
across moderate, vigorous and total physical activity (PA). 
  Medium compared to low PA level High compared to low PA level 
Variable PA OR 95% CI P-value OR 95% CI P-value 
CAVI 
Total 0.87 0.65 1.17 0.36 0.76 0.57 1.02 0.07 
Vigorous 0.91 0.65 1.27 0.60 0.65 0.48 0.88 <0.01 
Moderate 0.75 0.56 1.01 0.06 0.75 0.56 1.01 0.06 
baPWV 
Total 0.94 0.68 1.29 0.69 0.91 0.66 1.24 0.53 
Vigorous 0.93 0.64 1.34 0.69 0.67 0.48 0.93 0.02 
Moderate 0.89 0.64 1.22 0.46 0.94 0.69 1.28 0.69 
 
4 
 
Table 3. Adjusted estimates of the association between physical activity (PA) levels and continuous cardio-ankle vascular index (CAVI). 
  
Model 1 Model 2 Model 3 Model 4  
 
Unit Coef. 95% CI 
P-
value AIC Coef. 95% CI 
P-
value AIC Coef. 95% CI 
P-
value AIC Coef. 95% CI 
P-
value AIC 
Adjusted 
(Model 4) 
CAVI mean 
Moderate PA level   N=1908    
 
5766 N=1896    
 
4710 N=1890    
 
4620 N=1890    
 
4613 Low: 8.67 
medium vs. low 
MET-
min/week -0.05 
-
0.18 0.07 0.39  -0.10 
-
0.20 
-
0.01 0.03  -0.09 
-
0.18 
-
0.00 0.05  -0.10 
-
0.19 
-
0.01 0.03  
Medium: 8.57 
high vs. low 
MET-
min/week -0.03 
-
0.15 0.10 0.66  -0.08 
-
0.17 0.01 0.09  -0.077 
-
0.17 0.01 0.10  -0.08 
-
0.18 0.01 0.08  
High: 8.59 
Vigorous PA level  
 
N=1898    
 
5694 N=1886    
 
4686 N=1880    
 
4593 N=1880    
 
4588 Low: 8.64 
medium vs. low 
MET-
min/week -0.29 
-
0.43 
-
0.16 <0.001  -0.06 
-
0.17 0.04 0.24  -0.05 
-
0.16 0.05 0.32  -0.06 
-
0.16 0.04 0.26  
Medium: 8.58 
high vs. low 
MET-
min/week -0.39 
-
0.50 
-
0.27 <0.001  -0.10 
-
0.19 0.01 0.04  -0.11 
-
0.20 
-
0.02 0.02  -0.11 
-
0.20 
-
0.02 0.02  
High: 8.53 
Total PA level  
 
N=1908    
 
5763 N=1896    
 
4710 N=1890    
 
4619 N=1890    
 
4613 Low: 8.67 
medium vs. low 
MET-
min/week -0.06 
-
0.18 0.06 0.35  -0.08 
-
0.17 0.02 0.10  -0.08 
-
0.17 0.01 0.09  -0.08 
-
0.17 0.01 0.08  
Medium: 8.59 
high vs. low 
MET-
min/week -0.11 
-
0.24 0.01 0.07  -0.10 
-
0.19 
-
0.01 0.04  -0.10 
-
0.19 
-
0.01 0.03  -0.10 
-
0.20 
-
0.01 0.03  
High: 8.56 
 
AIC, Akaike Information Criterion; MET, metabolic equivalent. 
Model 1: univariable including a random area effect 
Model 2: further adjusted for age, sex, body mass index, education and packyears of smoking 
Model 3: further adjusted for mean arterial pressure, heart rate and medication  
Model 4: further adjusted for interactions age-sex and sex-mean arterial pressure 
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Table 4. Adjusted estimates of the association between physical activity (PA) levels and continuous brachial-ankle pulse wave velocity (baPWV). 
  
Model 1   
 
 Model 2   
 
 Model 3   
 
 Model 4   
 
  
 
Unit Coef. 95% CI P-value AIC Coef. 95% CI P-value AIC Coef. 95% CI P-value AIC Coef. 95% CI P-value AIC 
Adjusted (Model 4) PWV 
mean [m/s] 
Moderate PA level  
 
N=1907   
 
8623 N=1895   
 
7722 N=1889   
 
6968 N=1889   
 
6972 Low: 13.80 
medium vs. low MET-min/week -0.21 
-
0.48 0.05 0.11  -0.27 
-
0.48 
-
0.06 0.01  -0.16 
-
0.33 0.01 0.06  -0.16 
-
0.33 0.01 0.06  
Medium: 13.63 
high vs. low MET-min/week -0.10 
-
0.36 0.16 0.45  -0.18 
-
0.38 0.03 0.09  -0.10 
-
0.27 0.07 0.24  -0.10 
-
0.27 0.07 0.25  
High: 13.70 
Vigorous PA level  
 
N=1897   
 
8535 N=1885   
 
7688 N=1879   
 
6937 N=1879   
 
6940 Low: 13.77 
medium vs. low MET-min/week -0.77 
-
1.05 
-
0.48 <0.001  -0.19 
-
0.43 0.04 0.11  -0.10 
-
0.29 0.10 0.33  -0.10 
-
0.29 0.10 0.31  
Medium: 13.67 
high vs. low  MET-min/week -0.81 
-
1.06 
-
0.56 <0.001  -0.15 
-
0.35 0.06 0.17  -0.17 
-
0.34 0.01 0.06  -0.16 
-
0.33 0.01 0.06  
High: 13.60 
Total PA level  
 
N=1907   
 
8623 N=1895   
 
7725 N=1889   
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